发明授权
- 专利标题： Pharmaceutical composition for diabetic neuropathy
- 专利标题（中）： 糖尿病性神经病的药物组合物
-
申请号： US11098439申请日： 2005-04-05
-
公开(公告)号： US07074773B2公开(公告)日： 2006-07-11
- 发明人: Kazuki Endo , Toichi Abiru , Junzo Kamei
- 申请人： Kazuki Endo , Toichi Abiru , Junzo Kamei
- 申请人地址： JP Chiba
- 专利权人： Yamasa Corporation
- 当前专利权人： Yamasa Corporation
- 当前专利权人地址： JP Chiba
- 代理机构： Wenderoth, Lind & Ponack, L.L.P.
- 优先权： JP2001-268156 20010905; JP2001-340838 20011106
- 主分类号： A61K31/70
- IPC分类号： A61K31/70 ; A01N43/04 ; C07H19/04 ; C07H19/20
摘要：
The present invention relates to an agent for the prophylaxis or treatment of diabetic neuropathy, which contains cytidine 5′-diphosphocholine (CDP-choline) as an active ingredient. The agent for the prophylaxis or treatment of diabetic neuropathy of the present invention is effective for neuropathy mainly caused by metabolic disturbance of carbohydrate and is also superior in safety. Neuropathy includes peripheral neuropathy and dysautonomia. CDP-choline is effective even by oral administration.
公开/授权文献
- US20050171051A1 Pharmaceutical composition for diabetic neuropathy 公开/授权日：2005-08-04
信息查询
